TrialAIDS (London, England)2011

Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.

Alison A Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.